ShopSpell

Angiogenesis and Direct Myocardial Revascularization [Paperback]

$109.99     $119.99   8% Off     (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1617373931
  • ISBN-10:  1617373931
  • ISBN-13:  9781617373930
  • ISBN-13:  9781617373930
  • Publisher:  Humana
  • Publisher:  Humana
  • Pages:  372
  • Pages:  372
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Mar-2010
  • Pub Date:  01-Mar-2010
  • SKU:  1617373931-11-SPRI
  • SKU:  1617373931-11-SPRI
  • Item ID: 100717943
  • List Price: $119.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 31 to Nov 02
  • Notes: Brand New Book. Order Now.

An interdisciplinary panel of pioneers and opinion leaders review the basic, preclinical, clinical, and developmental pathways to new treatment strategies, such as therapeutic angiogenesis and myogenesis. The authors take advantage of new biological understanding, novel therapeutic targets, multiple available and well-studied therapeutic strategies, and the necessary imaging techniques to measure outcomes. Their in-depth discussions cover the identification of new therapeutic targets and pathways, the investigation of transcriptional factors, master switch molecules, cell-based approaches, chemokines, a better understanding of the effects of aging, endothelial dysfunction, and hypercholesterolemia in response to angiogenic stimuli. Highlights include examination of drug delivery problems, outcomes measure, stem therapy, high-risk interventions, development pathways, and future possibilities.An interdisciplinary panel of pioneers and opinion leaders review the basic, preclinical, clinical, and developmental pathways to new treatment strategies, such as therapeutic angiogenesis and myogenesis. The authors take advantage of new biological understanding, novel therapeutic targets, multiple available and well-studied therapeutic strategies, and the necessary imaging techniques to measure outcomes. Their in-depth discussions cover the identification of new therapeutic targets and pathways, the investigation of transcriptional factors, master switch molecules, cell-based approaches, chemokines, a better understanding of the effects of aging, endothelial dysfunction, and hypercholesterolemia in response to angiogenic stimuli. Highlights include examination of drug delivery problems, outcomes measure, stem therapy, high-risk interventions, development pathways, and future possibilities.No-Option Patients: A Growing ProblemRoger J. Laham and Donald S. BaimTranscriptional Regulation of AngiogenesisPeter OettgenPreclinical Models and Experience to DateAysegul Yegin and Nicolas lă#

Add Review